Q3 2024 Earnings Call Transcript November 4, 2024 Medifast, Inc. beats earnings expectations. Reported EPS is $0.1029, ...

Despite a significant revenue drop, Medifast Inc (MED) focuses on innovation and strategic marketing to counteract market pressures and competition.

The weight loss segment of the health and wellness ... a decrease of 36.3% from the third quarter of 2023. Average revenue per active earning OPTAVIA Coach for the second quarter was $4,672 ...

Real-time index price for TSX 60 Equal Weight Index (TXEW), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

If you are among the 70% of adults in the U.S. who are overweight and want to make a change, a weight loss program could ... by U.S. News and World Report. “Optavia provides personalized ...

“Medical innovation has transformed the weight loss industry, so at Medifast we ... Chairman & CEO. Known for its Optavia program that combines portion-controlled meal replacements with ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...